Novartis India Share Price in 2008: Chart, Monthly Trends, & Analysis

How did Novartis India shares perform in 2008?

Let's find out!

Novartis India share price in 2008 was ₹274.8 Its price on 1st January 2008 was ₹410.5, and by 31st December 2008 it moved to ₹274.8, giving a negative return of -33.06% for the year.

Novartis India Share Open, High, Low, and Close prices for the Year 2008 are as follows:

Open	High	Low	Close
₹410.5	₹440	₹221	₹274.8
1st Jan 2008	Occured in Jan 2008	Occured in Oct 2008	31st Dec 2008

This page will help you understand how Novartis India performed in 2008. Let's get started.

For complete insights into Novartis India’s incredible stock price performance and growth, see: Novartis India Historical Share Price Data from its IPO to 2025

Table: Novartis India Share Monthly Close, Low, High Prices for 2008

Month	Novartis India	Change%	↑High - ↓Low
Jan	₹325.14	-	↑ ₹440 ↓ ₹311
Feb	₹313.89	-3.5%	↑ ₹334 ↓ ₹285
Mar	₹306.14	-2.5%	↑ ₹321 ↓ ₹281
Apr	₹310.95	1.5%	↑ ₹319 ↓ ₹289
May	₹294.2	-5.4%	↑ ₹332 ↓ ₹292.39
Jun	₹280.3	-4.8%	↑ ₹310 ↓ ₹271.14
Jul	₹283.75	1.2%	↑ ₹289.5 ↓ ₹268.25
Aug	₹295.05	3.9%	↑ ₹315 ↓ ₹280.7
Sep	₹263.39	-10.8%	↑ ₹302 ↓ ₹256.05
Oct	₹253.7	-3.7%	↑ ₹264.8 ↓ ₹221
Nov	₹229.7	-9.5%	↑ ₹275 ↓ ₹229
Dec	₹274.8	19.6%	↑ ₹281 ↓ ₹225.1

Chart: CandleStick and Line Chart Showing Monthly Prices

[Click on line name to show/hide a line]

What if You invested ₹10,000 in Novartis India in 2008?

In 2008, the opening price of Novartis India share was ₹410.50. Today, the price stands at ₹672.25, reflecting a growth of 63.76%. If we applying the same growth to your investment of ₹10,000 then, your investment of ₹10,000 in 2008 would have become ₹16,376.37 by 2025. This represents a CAGR of 2.94%.

---

You might also like to check: Novartis India Stock Price in 2007 or Novartis India Stock Price in 2009

---

References: Stock prices on stockpricearchive.com are gathered from reliable sources only. We take prices from stock exchanges only, majorly from BSE and NSE.

Disclaimer: Information is provided ‘as is’ and solely for informational purposes, not for trading purposes or advice.